Sansure Biotech Inc. (SHA:688289)
China flag China · Delayed Price · Currency is CNY
14.76
-0.25 (-1.67%)
Nov 17, 2026, 3:00 PM CST

Sansure Biotech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
66.65153.92226.27348.171,9372,243
Depreciation & Amortization
209.38209.38151.47116.989.0753.94
Other Amortization
21.621.619.119.878.355.01
Loss (Gain) From Sale of Assets
2.952.952.360.250.31-2.83
Asset Writedown & Restructuring Costs
-37.73-37.73-5.31-54.8821.692.42
Loss (Gain) From Sale of Investments
55.2455.2433.7-253.74-79.24-81.01
Provision & Write-off of Bad Debts
31.7831.7813.714.9845.9618.49
Other Operating Activities
188.3145.59-25.6-13.92271.8336.64
Change in Accounts Receivable
-39.97-39.97153.01376.54-496.51-304.14
Change in Inventory
-10.31-10.3136.46-78.3-282.1-93.03
Change in Accounts Payable
-110.13-110.13-305.37-421.31,0223.12
Change in Other Net Operating Assets
-129.04-129.04-27.17-42.1660.853.84
Operating Cash Flow
239.4183.96274.4543.542,5591,877
Operating Cash Flow Growth
19.73%-32.97%530.34%-98.30%36.33%-28.96%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-350.79-369.77-421.1-391.35-558.83-372.86
Sale of Property, Plant & Equipment
0.842.440.250.720.0115.94
Cash Acquisitions
-715.47-715.47-1.07-113-11.59-
Divestitures
---58.28---
Sale (Purchase) of Real Estate
-----1.77
Investment in Securities
443.15-209.86363.671,791-642.46-834.95
Other Investing Activities
-158.036.4614.61110.0346.1377.88
Investing Cash Flow
-780.3-1,286-101.921,398-1,167-1,112

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1,107403.1318--
Total Debt Issued
510.131,107403.1318--
Short-Term Debt Repaid
------55
Long-Term Debt Repaid
--410.34-31.29-23.91-17.18-6.27
Lease Payments
-7.21-7.21-22.29-15.91-17.18-6.27
Total Debt Repaid
-110.02-410.34-31.29-23.91-17.18-61.27
Net Debt Issued (Repaid)
400.11696.28371.84-5.91-17.18-61.27
Issuance of Common Stock
11.7811.7821.45---
Repurchase of Common Stock
----122.73-257.41-200.01
Common Dividends Paid
-182.1-333.68-268.4-400.46-656.93-439.89
Other Financing Activities
-41.19-7.616015.5712.58
Financing Cash Flow
188.6374.38132.49-369.11-915.95-688.59

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-11.76-2.23-00.34-10.01-34.25
Net Cash Flow
-364.06-730.09305.011,073466.2442.01

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-111.39-185.81-146.66-347.812,0001,504
Free Cash Flow Growth
----32.97%-40.63%
Free Cash Flow Margin
-6.75%-11.32%-10.06%-34.53%31.01%33.32%
Free Cash Flow Per Share
-0.19-0.32-0.25-0.593.422.56
Levered Free Cash Flow
-263.25138.16-206.02-227.681,293898.55
Unlevered Free Cash Flow
-246.44152.72-194.52-226.171,295899.06
Free Cash Flow After Leases
-118.59-193.01-168.94-363.721,9831,498

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----0.32
Cash Income Tax Paid
94.6190.36112.34121.48493.44466.25
Change in Working Capital
-298.77-298.77-141.26-124.08264.17-398.29